ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
177 hedge funds and large institutions have $2.92B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 20 closing their positions.
421% more call options, than puts
Call options by funds: $165M | Put options by funds: $31.7M
105% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 20
29% more capital invested
Capital invested by funds: $2.27B → $2.92B (+$653M)
14% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 59
13% more funds holding
Funds holding: 157 → 177 (+20)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$79.4M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$77.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$14.2M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$13.6M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$48M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$38M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$29.6M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$26.2M |
| 5 |
Bank of New York Mellon
New York
|
-$22M |
ANAC Hedge Fund Activity: Q2 2015 in Review
177 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2015, worth a combined $2.92B — up 29% from $2.27B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new ANAC positions and 20 closed out — a net gain of 21 holders — while 67 added to existing stakes and 59 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $79.4M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $48M sold.
- 177 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2015, up from 157 in Q1 2015.
- Funds reported $2.92B of ANACOR PHARMACEUTICALS INC COM stock for Q2 2015, up 29% quarter-over-quarter.
- 41 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2015 and 20 closed out, a net change of +21 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2015 was Fidelity Investments, an estimated $79.4M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2015 was Consonance Capital Management, an estimated $48M sold.
Based on aggregated 13F filings for Q2 2015.